Transient suppression of resting corticosterone levels induces sustained increase of AVP stores in hypothalamic CRH-neurons of rats

Journal of Neuroendocrinology

Volumn 9, Issue 1, 1997, Pages 69-77

  Schmidt, E D ^a   Janszen, A W J W ^a   Binnekade, R ^a   Tilders, F J H ^a,b  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Corticosterone; Corticotropin releasing hormone; Feedback; Hypothalamus pituitary adrenal axis; Vasopressin

Indexed keywords

ARGIPRESSIN; CORTICOSTERONE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; METYRAPONE;

ADRENALECTOMY; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; HYPOTHALAMUS; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

ADRENALECTOMY; ADRENOCORTICOTROPIC HORMONE; ANIMALS; ARGININE VASOPRESSIN; CORTICOSTERONE; CORTICOTROPIN-RELEASING HORMONE; ETHER, ETHYL; HYPOTHALAMUS; IMMUNIZATION, PASSIVE; MALE; MEDIAN EMINENCE; METYRAPONE; NEURONS; RATS; RATS, WISTAR; STRESS;

EID: 0031019272     PISSN: 09538194     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2826.1997.00618.x     Document Type: Article

References (64)

1. Antoni FA. Hypothalamic control of secretion: advances since the discovery of 41-residue corticotropin-releasing factor. Endocr Rev 1986; 7: 351-378.
2. Tilders FJH, Schmidt ED, De Goeij DCE. Phenotypic plasticity of CRF neurons during stress. (Review). Ann NY Acad Sci 1993; 697: 39-52.
3. Ceccatelli S, Eriksson M, Hökfelt T. Distribution and coexistence of corticotropin-releasing factor-, neurotensin-, enkephalin-, cholecystokinin-, galanin- and vasoactive intestinal polypeptide/peptide histidine isoleucine-like peptides in the parvocellular part of the paraventricular nucleus. Neuroendocrinology 1989; 49: 309-323.
4. Meister B, Villar MJ, Ceccatelli S, Hökfelt T. Localization of chemical messengers in magnocellular neurons of the hypothalamic supraoptic and paraventricular nuclei: an immunohistochemical study using experimental manipulations. Neuroscience 1990; 37: 60-633.
5. Whitnall MH. Regulation of the hypothalamic corticotropin-releasing hormone neurosecretory system (Review). Progr Neurobiol. 1993; 40: 573-629.
6. Bartanusz V, Jezova D, Bertini LT, Tilders FJH, Aubry JM, Kiss JZ. Stress-induced increase in vasopressin and corticotropin-releasing factor expression in hypophysiotrophic paraventricular neurons. Endocrinology 1993; 132: 895-902.
7. Plotsky PM, Sawchenko PE. Hypophysial-portal plasma levels, median eminence content, and immunohistochemical staining of corticotropin-releasing factor, arginine vasopressin, and oxytocin after pharmacological adrenalectomy. Endocrinology 1987; 120: 1361-1369.
8. De Goeij DCE, Binnekade R, Tilders FJH. Chronic stress enhances vasopressin but not corticotropin-releasing factor secretion during hypoglycemia. Am J Physiol 1992; 263: E394-E399.
9. De Goeij DCE, Berkenbosch F, Tilders FJH. Is vasopressin preferentially released from corticotropin-releasing factor and vasopressin containing nerve terminals in the median eminence of adrenalectomized rats? J Neuroendocrinol 1993; 5: 107-113.
10. Schmidt ED, Janszen AWJW, Wouterlood FG, Tilders FJH. Interleukin-1 induced long-lasting changes in hypothalamic corticotropin-releasing hormone (CRH)-neurons and hyperresponsiveness of the hypothalamus-pituitary-adrenal axis. J Neurosci. 1995; 15: 7417-7426.
11. Van Dijken HH, De Goeij DCE, Sutanto W, Mos J, de Kloet ER, Tilders FJH. Short inescapable stress produces long-lasting changes in the brain-pituitary-adrenal axis of adult male rats. Neuroendocrinology 1993; 58: 57-64.
12. Schmidt ED, Binnekade R, Janszen AWJW, Tilders FJH. A single stress exposure can induce long-lasting increases of vasopressin stores in hypothalamic corticotropin-releasing-hormone CRH neurons in adult rats. J Neuroendocrinol 1996; 8: 703-71.
13. Bertini LT, Kursner C, Gaillard RC, Corder R, Kiss JZ. A tissue culture model of the hypophysiotrophic CRF producing neuronal system. Neuroendocrinology 1993; 57: 716-728.
14. Strbak V, Guillaume V, Grino M, Dutour A, Burlet AJ, Oliver C. Passive immunization and hypothalamic peptide secretion. Neuroendocrinology 1993; 58: 210-217.
15. De Souza EB, Insel TR, Perrin MH, Rivier J, Vale WW, Kuhar MJ. Corticotropin-releasing factor receptors are widely distributed within the rat central nervous system: an autoradiographic study. J Neurosci 1985; 5: 3189-3203.
16. Van Oers JWAM, Tilders FJH, Berkenbosch F. Characterization and biological activity of a rat monoclonal antibody to rat/human corticotropin releasing factor. Endocrinology 1989; 124: 1239-1246.
17. Van Oers JWAM, van Bree C, White A, Tilders FJH. Antibodies to neuropeptides as alternatives for peptide receptor antagonists in studies on the physiological actions of neuropeptides. In: Joosse J, Buijs RM, Tilders FJH, eds. The Peptidergic Neuron. Elsevier Science Publishers B.V. Prog Brain Res 1992; 92: 225-234.
18. Van Oers JWAM, van Bree C, White A, Tilders FJH. Antibodies to neuropeptides as alternatives for peptide receptor antagonists in studies on the physiological actions of neuropeptides. In: Joosse J, Buijs RM, Tilders FJH, eds. The Peptidergic Neuron. Elsevier Science Publishers B.V. Prog Brain Res 1992; 92: 225-234.
19. Van Oers JWAM, Tilders FJH. Antibodies in passive immunization studies: characteristics and consequences. Endocrinology 1991; 128: 496-503.
20. Van Oers JWAM, Tilders, FJH, Berkenbosch, F. Acute and long-term suppression of stress-induced ACTH responses by a rat monoclonal antibody to Corticotropin Releasing Factor. In: Miller EE, Macleod RM, eds. Neuroendocrine Perspectives. New York, Berlin, Heidelberg, London, Paris, Tokyo: Springer-Verlag, 1988; 287-292.
21. Berkenbosch F, De Goeij DCE, Tilders FJH. Hypoglycemia enhances turnover of corticotropin-releasing factor and of vasopressin in the zona externa of the rat median eminence. Endocrinology 1989; 125: 28-34.
22. Tilders FJH, De Goeij DCE, Berkenbosch F. Turnover of corticotropin releasing factor and vasopressin in the median eminence and control of pituitary-adrenal activity. In: Rose FC, ed. The control of the Hypothalamo-Pituitary-Adrenal Axis. Madison, WI, USA: International University Press, 1989: 7-24.
23. Ixart G, Conte-Devolx B, Szafarczyk A et al. Passive immunization with an anti-oCRF41 immune serum inhibits the circadian increase of plasma ACTH in rats. CR Acad Sci III 1985; 301: 659-664.
24. Van Oers JWAM, Tilders FJ. Non-adrenocorticotropin mediated effects of endogenous corticotropin-releasing factor on the adrenocortical activity in the rat. J Neuroendocrinol. 1991; 3: 119-121.
25. Bagdy G, Chrousos GP, Calogero AE. Circadian patterns of plasma immunoreactive corticotropin, beta-endorphin, corticosterone and prolactin after immunoneutralization of corticotropin-releasing hormone. Neuroendocrinology 1991; 53: 573-578.
26. Herman JP, Schafer MK, Thompson RC, Watson SJ. Rapid regulation of corticotropin-releasing hormone gene transcription in vivo. Mol Endocrinol 1982; 6: 1061-1069.
27. Herman JP, Wiegand SJ, Watson SJ. Regulation of basal corticotropin-releasing hormone and arginine vasopressin messenger ribonucleic acid expression in the paraventricular nucleus: effects of selective hypothalamic deafferentations. Endocrinology 1990; 127: 2408-2417.
28. Herman JP, Cullinan WE, Young EA, Akil H, Watson SJ. Selective forebrain fiber tract lesions implicate ventral hippocampal structures in tonic regulation of paraventricular nucleus corticotropin-releasing hormone (CRH) and arginine vasopressin (AVP) mRNA expression. Brain Res 1992; 592: 228-238.
29. Piva F, Celotti F, Dondi D, Limonta P, Maggi R, Mesi E, Negri-Cesi P, Zanisi M, Motta M, Martin L. Ageing of the neuroendocrine system in the brain of male rats: receptor mechanisms and steroid metabolism (Review). J Reprod Fert-Suppl 1993; 46: 47-59.
30. Wong ML, Licinio J, Pasternak KI, Gold PW. Localization of corticotropin-releasing hormone (CRH) receptor mRNA in adult rat brain by in situ hybridization histochemistry. Endocrinology 1994; 135: 2275-2278.
31. Menzaghi F, Burlet AJ, Van Oers JWAM, Tilders FJH, Nicolas JP, Burlet C. Long-term inhibition of stress-induced adrenocorticotropin release by intracerebral administration of a monoclonal antibody to rat corticotropin-releasing factor together with ricin A chain and monensin. J Neuroendocrinol 1991; 3: 469-475.
32. Tilders FJH, Van Oers JWAM, White A, Menzaghi F, Burlet A. Antibodies to neuropeptides: biological effects and mechanisms of action. Adv Exp Med Biol 1990; 274: 135-145.
33. Ono N, Bedran de Castro JC, McCann SM. Ultrashort-loop positive feedback of corticotropin (ACTH)-releasing factor to enhance ACTH release in stress. Proc Natl Acad Sci. 1985; 82: 3528-3531.
34. Parkes D, Rivest S, Lee S, Rivier C, Vale W. Corticotropin-releasing factor activates c-fos, NGFI-B, and corticotropin-releasing factor gene expression within the paraventricular nucleus of the rat hypothalamus. Mol Endocrinology 1993; 7: 1357-1367
35. Imaki T, Shibasaki T, Hotta M, Demura H. Intracerebroventricular administration of corticotropin-releasing factor induces c-fos mRNA expression in brain regions related to stress responses: comparison with pattern of c-fos mRNA induction after stress. Brain Res 1993; 616: 114-125.
36. Luo X, Kiss A, Makara G, Lolait SJ, Aguilera G. Stress-specific regulation of corticotropin releasing hormone receptor expression in the paraventricular and supraoptic nuclei of the hypothalamus in the rat. J Neuroendocrinol 1994; 6: 689-696.
37. Makino S, Schulkin J, Smith MA, Pacak K, Palkovits M, Gold PW. Regulation of corticotropin-releasing hormone receptor messenger ribonucleic acid in the rat brain and pituitary by glucocorticoids and stress. Endocrinology 1995; 136: 4517-4525.
38. Sawchenko PE, Arias C. Evidence for short-loop feedback effects of ACTH and Vasopressin expression in parvocellular neurosecretory neurons. J Neuroendocrinol 1995; 7: 721-731.
39. Alexander SL, Irvine CH, Livesey JH, Donald RA. The acute effect of lowering plasma Cortisol on the secretion of corticotropin-releasing hormone, arginine vasopressin, and adrenocorticotropin as revealed by intensive sampling of pituitary venous blood in the normal horse. Endocrinology 1993; 133: 860-866.
40. Covenas R, de Leon M, Cintra A, Bjelke B, Gustafsson JA, Fuxe K. Coexistence of c-Fos and glucocorticoid receptor immunoreactivities in the CRF immunoreactive neurons of the paraventricular hypothalamic nucleus of the rat after acute immobilization stress. Neurosci Lett 1993; 149: 149-152.
41. Hu SB, Tannahill LA, Biswas S, Lightman SL. Release of corticotrophin-releasing factor-41, arginine vasopressin and oxytocin from rat fetal hypothalamic cells in culture: response to activation of intracellular second messengers and to corticosteroids. J Endocrinology 1992; 132: 57-65.
42. Feldman S, Saphier D, Weidenfeld J. Corticosterone implants in the paraventricular nucleus inhibit ACTH and corticosterone responses and the release of corticotropin-releasing factor following neural stimuli. Brain Res 1992; 578: 251-255.
43. Makino S, Smith MA, Gold PW. Increased expression of corticotropin-releasing hormone and vasopressin messenger ribonucleic acid (mRNA) in the hypothalamic paraventricular nucleus during repeated stress: association with reduction in glucocorticoid receptor mRNA levels. Endocrinology 1995; 136: 3299-3309.
44. Marti O, Gavalda A, Gomez F, Armario A. Direct evidence for chronic stress-induced facilitation of the adrenocorticotropin response to a novel acute Stressor. Neuroendocrinology 1994; 60: 1-7.
45. Fiad TM, Kirby JM, Cunningham SK, McKenna TJ. The overnight single-dose metyrapone test is a simple and reliable index of the hypothalamic-pituitary-adrenal axis. Clin Endocrinol 1994; 40: 603-609.
46. Steiner H, Bahr V, Exner P, Oelkers PW. Pituitary function tests: comparison of ACTH and 11-deoxy-cortisol responses in the metyrapone test and with the insulin hypoglycemia test. Exp Clin Endocrinol 1994; 102: 33-38.
47. O'Dwyer AM, Lightman SL, Marks MN, Checkley SA. Treatment of major depression with metyrapone and hydrocortisone. J Affect Dis 1995; 33: 123-128.
48. Ghadirian AM, Engelsmann F, Dhar V, Filipini D, Keller R, Chouinard G, Murphy BE. The psychotropic effects of inhibitors of steroid biosynthesis in depressed patients refractory to treatment. Biol Psych 1995; 37: 369-375.
49. Murphy BE, Dhar V, Ghadirian AM, Chouinard G, Keller R. Response to steroid suppression in major depression resistant to antidepressant therapy. J Clin Psychopharmacol 1991; 11: 121-126.
50. Fahlke C, Hard E, Thomasson R, Engel JA, Hansen S. Metyrapone-induced suppression of corticosterone synthesis reduces ethanol consumption in high-preferring rats. Pharm Biochem Beh 1994; 48: 977-981.
51. Piazza PV, Marinelli M, Jodogne C, Deroche V, Rouge-Pont F, Maccari S, LeMoal M, Simon H. Inhibition of corticosterone synthesis by metyrapone decreases cocaine-induced locomotion and relapse of cocaine self-administration. Brain Res 1994; 658: 259-264.
52. Bartanusz V, Aubry JM, Jezova D, Baffi J, Kiss JZ. Up-regulation of vasopressin mRNA in paraventricular hypophysiotrophic neurons after acute immobilization stress. Neuroendocrinology 1993; 58: 625-629.
53. Maren S, Baudry M. Properties and mechanisms of long-term synaptic plasticity in the mammalian brain: relationships to learning and memory. Neurobiol Learn Mem 1995; 63: 1-18.
54. Van Dijken HH, van der Heijden JA, Mos J, Tilders FJH. Inescapable footshocks induce progressive and long-lasting behavioral changes in male rats. Physiol Behav 1992; 51: 787-794.
55. Post RM, Weiss SRB. The neurobiology of treatment-resistant mood disorders. In: Bloom FE, Kupfer, eds. Psychopharmacology: the fourth generation of progress. New York: Raven Press, 1995: 1155-1170.
56. Ono N, Samson WK, McDonald JK, Lumpkin MD, Bedran de Castro JC, McCann SM. Effects of intravenous and intraventricular injection of antisera directed against corticotropin-releasing factor on the secretion of anterior pituitary hormones. Proc Natl Acad Sci 1985; 82: 7787-7790
57. Steffens AB. A method for frequent sampling in blood continuous infusion of fluids in the rats without disturbing the animal. Physiol Behav 1969; 4: 833-839.
58. Van Oers JWA, Hinson JP, Binnekade R, Tilders FJH. Physiological role of corticotropin-releasing factor in the control of adrenocorticotropin-mediated corticosterone release from the rat adrenal gland. Endocrinology 1992; 130: 282-288.
59. Kovacs KJ, Makara GB. Corticosterone and dexamethasone act at different brain sites to inhibit adrenalectomy induced adrenocorticotropin hypersecretion. Brain Res 1988; 474: 205-210.
60. DeMan AJM, Benraad TJ. Aldosterone secretion rate: radioimmunoassay versus double isotope dilution derivative assay. Clin Chim Acta 1977; 79: 489-501.
61. Berkenbosch F, Tilders FJH. Effect of axonal transport blockade on corticotropin-releasing factor immunoreactivity in the median eminence of intact and adrenalectomized rats: relationship between depletion rate and secretory activity. Brain Res 1988; 442: 312-320.
62. Koenig JI, Klippel RA. The rat brain. A stereotactic atlas of the forebrain and lower parts of the brainstem. USA: William & Wilkins, Baltimore, 1963.
63. Van der Sluis PJ, Pool CW, Sluiter AA. Immunochemical detection of peptides and proteins on press-blots after direct tissue gel isoelectric focussing. Electrophoresis 1988; 9: 654-661.
64. Berkenbosch F, Limon EA, Tilders FJH. Colocalization of peptide histidine isoleucine amine and corticotropin-releasing factor immunoreactivity in neurons of the rat hypothalamus: a surprising artefact. Neuroendocrinology 1986; 44: 338-346.